OLOPATADINE

OLOPATADINE was reported 5840 times

OLOPATADINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COXSACKIE VIRUS TEST POSITIVE 2 0.1000
1 PULMONARY TRICHOSPORONOSIS 2 0.0870
2 CYSTIC FIBROSIS HEPATIC DISEASE 2 0.0870
3 VERNAL KERATOCONJUNCTIVITIS 4 0.0800
4 GIANT PAPILLARY CONJUNCTIVITIS 3 0.0600
5 COLD URTICARIA 9 0.0409
6 CORYNEBACTERIUM SEPSIS 2 0.0303
7 CATARACT CORTICAL 4 0.0268
8 BLOOD LACTATE DEHYDROGENASE 2 0.0247
9 ALLERGY TO ARTHROPOD BITE 7 0.0219
10 FACTITIOUS DISORDER 3 0.0199
11 HEART VALVE CALCIFICATION 3 0.0150
12 OCULAR SURFACE DISEASE 4 0.0142
13 CYSTIC FIBROSIS RELATED DIABETES 2 0.0137
14 KERATOCONUS 5 0.0133
15 CORNEA VERTICILLATA 4 0.0132
16 AORTIC VALVE THICKENING 2 0.0124
17 BLOOD LACTIC ACID DECREASED 2 0.0116
18 DEAFNESS PERMANENT 2 0.0102
19 TREATMENT FAILURE 694 0.0084
20 CHRONIC LEFT VENTRICULAR FAILURE 3 0.0083
21 CORNEAL DEGENERATION 2 0.0083
22 DUST ALLERGY 8 0.0082
23 ILLNESS ANXIETY DISORDER 2 0.0081
24 XEROSIS 10 0.0081
25 RECTAL NEOPLASM 2 0.0076
26 CONJUNCTIVITIS ALLERGIC 11 0.0074
27 HEPATITIS C ANTIBODY POSITIVE 2 0.0074
28 PUTAMEN HAEMORRHAGE 2 0.0070
29 PULMONARY ARTERIAL PRESSURE ABNORMAL 2 0.0069
30 HEART FAILURE WITH PRESERVED EJECTION FRACTION 2 0.0068
31 MITRAL VALVE THICKENING 2 0.0067
32 MESENTERIC PANNICULITIS 2 0.0067
33 MEIBOMIAN GLAND DYSFUNCTION 3 0.0066
34 ALLERGY TO ANIMAL 7 0.0066
35 TYPE V HYPERLIPIDAEMIA 3 0.0062
36 CENTRAL SLEEP APNOEA SYNDROME 2 0.0062
37 MITE ALLERGY 4 0.0061
38 CORNEAL SCAR 3 0.0060
39 ENDOCRINE OPHTHALMOPATHY 5 0.0058
40 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
41 CORNEAL EROSION 3 0.0056
42 NASAL TURBINATE HYPERTROPHY 2 0.0053
43 CONJUNCTIVAL DISORDER 2 0.0052
44 COLON CANCER STAGE III 2 0.0052
45 HAEMANGIOMA OF SKIN 2 0.0046
46 EYE ALLERGY 7 0.0045
47 FALSE NEGATIVE INVESTIGATION RESULT 3 0.0043
48 FACIAL DISCOMFORT 3 0.0042
49 KERATIC PRECIPITATES 2 0.0042
50 HYPERGAMMAGLOBULINAEMIA 2 0.0041
51 LENTIGO 2 0.0040
52 APPLICATION SITE INFECTION 2 0.0039
53 AORTIC VALVE CALCIFICATION 2 0.0039
54 BONE MARROW OEDEMA 4 0.0039
55 PRODUCT DROPPER ISSUE 3 0.0038
56 THYROID HORMONES INCREASED 4 0.0038
57 INFUSION SITE VESICLES 2 0.0038
58 BLOOD OESTROGEN INCREASED 2 0.0034
59 CATARACT SUBCAPSULAR 2 0.0033
60 MITRAL VALVE CALCIFICATION 2 0.0031
61 EYELID RASH 3 0.0031
62 ENDOMETRITIS 2 0.0030
63 BRONCHITIS VIRAL 2 0.0030
64 CUTANEOUS SYMPTOM 2 0.0029
65 RADIOISOTOPE SCAN ABNORMAL 2 0.0028
66 HODGKIN'S DISEASE 2 0.0028
67 RUBBER SENSITIVITY 4 0.0026
68 CREATINE KINASE INCREASED 2 0.0026
69 BLISTER INFECTED 2 0.0026
70 METAPNEUMOVIRUS INFECTION 2 0.0026
71 PHARYNGEAL INFLAMMATION 3 0.0025
72 NEPHROGENIC ANAEMIA 11 0.0024
73 POUCHITIS 2 0.0023
74 DACRYOSTENOSIS ACQUIRED 3 0.0023
75 PERIPHERAL NERVE INJURY 2 0.0023
76 KYPHOSIS 4 0.0023
77 SKIN DISCOMFORT 6 0.0022
78 INFUSION SITE PRURITUS 7 0.0022
79 IRIDOCYCLITIS 7 0.0022
80 ULCERATIVE KERATITIS 6 0.0022
81 IMMUNOGLOBULINS DECREASED 3 0.0022
82 CERUMEN IMPACTION 2 0.0022
83 BONE CYST 2 0.0021
84 FOREIGN BODY IN EYE 2 0.0021
85 SEASONAL ALLERGY 29 0.0020
86 HYPERPARATHYROIDISM SECONDARY 5 0.0020
87 IMMUNE-MEDIATED DERMATITIS 2 0.0020
88 BODY TEMPERATURE FLUCTUATION 4 0.0019
89 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
90 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 10 0.0018
91 OCULAR TOXICITY 2 0.0018
92 ARTHROPOD STING 3 0.0018
93 HOMICIDAL IDEATION 7 0.0017
94 INFUSION SITE DISCHARGE 3 0.0017
95 ALOPECIA AREATA 3 0.0017
96 JC POLYOMAVIRUS TEST POSITIVE 2 0.0017
97 PANCREATIC FAILURE 3 0.0017
98 NASAL OEDEMA 3 0.0017
99 ASTHMATIC CRISIS 6 0.0016
100 ESSENTIAL HYPERTENSION 3 0.0016
101 AMPUTATION 2 0.0016
102 IMPAIRED QUALITY OF LIFE 23 0.0016
103 CHRONIC SINUSITIS 6 0.0016
104 SACROILIITIS 3 0.0016
105 IMMUNE-MEDIATED HEPATIC DISORDER 3 0.0015
106 ENCEPHALITIS AUTOIMMUNE 2 0.0015
107 RADICULOPATHY 4 0.0015
108 ANIMAL BITE 4 0.0015
109 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
110 CORNEAL OPACITY 2 0.0015
111 CORNEAL ABRASION 2 0.0015
112 INFUSION SITE RASH 2 0.0015
113 DISCHARGE 2 0.0014
114 LUNG ABSCESS 3 0.0014
115 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
116 CATAPLEXY 2 0.0014
117 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
118 CUTANEOUS VASCULITIS 5 0.0014
119 PULMONARY VALVE INCOMPETENCE 2 0.0014
120 AMYLASE INCREASED 5 0.0014
121 OBSTRUCTIVE AIRWAYS DISORDER 15 0.0013
122 IMPETIGO 2 0.0013
123 GASTROINTESTINAL WALL THICKENING 2 0.0013
124 EPICONDYLITIS 2 0.0013
125 RENAL TUBULAR NECROSIS 13 0.0013
126 MARASMUS 2 0.0013
127 INFECTIOUS PLEURAL EFFUSION 2 0.0013
128 EYE PRURITUS 44 0.0013
129 SINUS PAIN 3 0.0013
130 PRE-EXISTING CONDITION IMPROVED 8 0.0013
131 INFUSION SITE SWELLING 8 0.0013
132 PAINFUL RESPIRATION 3 0.0012
133 RHINITIS 10 0.0012
134 CEREBELLAR INFARCTION 2 0.0012
135 BLOOD AMYLASE INCREASED 2 0.0012
136 CERVICAL SPINAL STENOSIS 2 0.0012
137 ACUTE SINUSITIS 2 0.0012
138 EYE DISCHARGE 12 0.0012
139 EYE INFLAMMATION 11 0.0012
140 OTORRHOEA 2 0.0011
141 PAPULE 8 0.0011
142 CHONDROPATHY 3 0.0011
143 CYSTIC FIBROSIS 6 0.0011
144 ADRENAL INSUFFICIENCY 13 0.0011
145 BLADDER SPASM 2 0.0011
146 PERIORBITAL SWELLING 6 0.0011
147 BREAST MASS 7 0.0010
148 OCULAR HYPERTENSION 2 0.0010
149 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
150 CONJUNCTIVITIS 19 0.0010
151 THYROIDITIS 3 0.0010
152 HYPERCAPNIA 3 0.0010
153 EYE INJURY 3 0.0010
154 END STAGE RENAL DISEASE 18 0.0010
155 EYELID PAIN 2 0.0010
156 INFUSION SITE EXTRAVASATION 6 0.0010
157 CHOLECYSTECTOMY 11 0.0010
158 SWELLING OF EYELID 6 0.0010
159 NON-CARDIAC CHEST PAIN 3 0.0009
160 PSEUDOMONAS INFECTION 8 0.0009
161 EXOPHTHALMOS 2 0.0009
162 INFUSION SITE BRUISING 2 0.0009
163 LANGUAGE DISORDER 2 0.0009
164 BLOOD COUNT ABNORMAL 14 0.0009
165 CORNEAL DISORDER 2 0.0009
166 IMMUNE SYSTEM DISORDER 12 0.0009
167 DERMATITIS ATOPIC 48 0.0009
168 COLONOSCOPY 2 0.0009
169 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
170 AFFECTIVE DISORDER 7 0.0009
171 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
172 PERIARTHRITIS 2 0.0009
173 ASTHMA 98 0.0009
174 MOUTH SWELLING 5 0.0009
175 OCULAR HYPERAEMIA 41 0.0009
176 ERYTHEMA MULTIFORME 8 0.0009
177 JOINT DISLOCATION 9 0.0009
178 GLOSSITIS 3 0.0008
179 SINUS HEADACHE 5 0.0008
180 SYMPTOM RECURRENCE 5 0.0008
181 FACIAL BONES FRACTURE 3 0.0008
182 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
183 LYMPHADENITIS 2 0.0008
184 DRY EYE 41 0.0008
185 BRONCHITIS CHRONIC 2 0.0008
186 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
187 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
188 DEVICE INFUSION ISSUE 2 0.0008
189 LACRIMATION INCREASED 24 0.0008
190 HOSTILITY 2 0.0008
191 EAR DISCOMFORT 8 0.0008
192 SKIN NECROSIS 4 0.0008
193 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
194 PERSONALITY DISORDER 2 0.0008
195 HYPERSENSITIVITY VASCULITIS 2 0.0008
196 HYPERLACTACIDAEMIA 2 0.0007
197 BREAST SWELLING 2 0.0007
198 DRUG ERUPTION 13 0.0007
199 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
200 EYE IRRITATION 41 0.0007
201 ATYPICAL FEMUR FRACTURE 2 0.0007
202 MUSCLE FATIGUE 3 0.0007
203 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
204 INFUSION SITE PAIN 9 0.0007
205 HORDEOLUM 3 0.0007
206 EYELID MARGIN CRUSTING 2 0.0007
207 HAEMOTHORAX 2 0.0007
208 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
209 ANKYLOSING SPONDYLITIS 9 0.0007
210 LIGAMENT RUPTURE 3 0.0007
211 RHINITIS ALLERGIC 3 0.0007
212 PRODUCTIVE COUGH 32 0.0007
213 BRAIN HERNIATION 2 0.0007
214 WHEEZING 39 0.0007
215 PHARYNGITIS 8 0.0006
216 EYELIDS PRURITUS 2 0.0006
217 RESPIRATORY DISORDER 19 0.0006
218 FOREIGN BODY IN THROAT 2 0.0006
219 THROAT TIGHTNESS 17 0.0006
220 FOREIGN BODY SENSATION IN EYES 4 0.0006
221 SUBCUTANEOUS ABSCESS 3 0.0006
222 NEPHROPATHY TOXIC 7 0.0006
223 LOOSE TOOTH 2 0.0006
224 CHRONIC KIDNEY DISEASE 47 0.0006
225 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
226 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
227 LYMPHOCYTE COUNT INCREASED 2 0.0006
228 DEAFNESS NEUROSENSORY 2 0.0006
229 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
230 PULMONARY MASS 9 0.0006
231 PLANTAR FASCIITIS 2 0.0006
232 INFUSION SITE ERYTHEMA 5 0.0006
233 SINUSITIS 60 0.0006
234 VENTRICULAR EXTRASYSTOLES 6 0.0006
235 HYPERSENSITIVITY 107 0.0006
236 TONSILLITIS 3 0.0006
237 APLASTIC ANAEMIA 3 0.0006
238 BRAIN FOG 9 0.0006
239 SEROTONIN SYNDROME 11 0.0006
240 EAR PRURITUS 2 0.0006
241 NYSTAGMUS 3 0.0006
242 FIBRIN D DIMER INCREASED 2 0.0006
243 COMPRESSION FRACTURE 3 0.0006
244 INJECTION SITE DISCHARGE 3 0.0006
245 CARDIAC DISORDER 52 0.0006
246 RESTLESS LEGS SYNDROME 10 0.0005
247 INTRAOCULAR PRESSURE INCREASED 7 0.0005
248 AUTISM SPECTRUM DISORDER 3 0.0005
249 INCREASED TENDENCY TO BRUISE 5 0.0005
250 NECROSIS 3 0.0005
251 SNEEZING 12 0.0005
252 ANHEDONIA 14 0.0005
253 EYE INFECTION 6 0.0005
254 CARDIAC VALVE DISEASE 3 0.0005
255 PARANASAL SINUS HYPERSECRETION 2 0.0005
256 HYPERTONIA 3 0.0005
257 ACIDOSIS 4 0.0005
258 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
259 EXERCISE TOLERANCE DECREASED 3 0.0005
260 ANGIOEDEMA 23 0.0005
261 OESOPHAGEAL DISORDER 2 0.0005
262 ORTHOSTATIC HYPOTENSION 9 0.0005
263 CONCUSSION 4 0.0005
264 SKIN WARM 3 0.0005
265 EPIGASTRIC DISCOMFORT 2 0.0005
266 MULTIPLE ALLERGIES 4 0.0005
267 DYSPNOEA EXERTIONAL 19 0.0005
268 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
269 GOITRE 2 0.0005
270 ANAPHYLACTOID REACTION 2 0.0005
271 CYST 6 0.0005
272 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
273 SECRETION DISCHARGE 6 0.0005
274 ECZEMA 25 0.0005
275 DERMATITIS 10 0.0005
276 BLEPHAROSPASM 3 0.0005
277 FOOT FRACTURE 9 0.0005
278 INTESTINAL STENOSIS 2 0.0005
279 SLEEP APNOEA SYNDROME 9 0.0005
280 MENTAL STATUS CHANGES 13 0.0005
281 ALCOHOLISM 2 0.0005
282 HEREDITARY ANGIOEDEMA 5 0.0005
283 HERPES SIMPLEX 3 0.0005
284 DELIRIUM 16 0.0005
285 BIPOLAR DISORDER 5 0.0005
286 IMMOBILE 2 0.0005
287 MELANOCYTIC NAEVUS 2 0.0005
288 DYSPHEMIA 2 0.0005
289 CATHETERISATION CARDIAC 2 0.0005
290 LIP SWELLING 15 0.0004
291 RHINORRHOEA 29 0.0004
292 CYTOKINE RELEASE SYNDROME 9 0.0004
293 MALNUTRITION 5 0.0004
294 GASTROINTESTINAL INFECTION 4 0.0004
295 GOUT 8 0.0004
296 BRONCHITIS 33 0.0004
297 SINUS CONGESTION 6 0.0004
298 PSORIATIC ARTHROPATHY 18 0.0004
299 EYE PAIN 25 0.0004
300 GASTROENTERITIS VIRAL 8 0.0004
301 OROPHARYNGEAL DISCOMFORT 4 0.0004
302 PERIPHERAL COLDNESS 6 0.0004
303 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
304 DYSPAREUNIA 2 0.0004
305 EYE OPERATION 2 0.0004
306 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
307 THINKING ABNORMAL 8 0.0004
308 MOUTH ULCERATION 9 0.0004
309 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
310 DISCOMFORT 26 0.0004
311 PHOTOPHOBIA 8 0.0004
312 ARTERIOSCLEROSIS 4 0.0004
313 SPINAL DISORDER 4 0.0004
314 COLITIS MICROSCOPIC 2 0.0004
315 ENDOMETRIOSIS 2 0.0004
316 SWOLLEN TONGUE 13 0.0004
317 VISUAL FIELD DEFECT 3 0.0004
318 HUMERUS FRACTURE 2 0.0004
319 TONGUE DISORDER 3 0.0004
320 RASH VESICULAR 2 0.0004
321 RASH PUSTULAR 3 0.0004
322 SLEEP DISORDER 29 0.0004
323 VERTIGO 25 0.0004
324 VITAMIN D DEFICIENCY 4 0.0004
325 HORMONE LEVEL ABNORMAL 2 0.0004
326 PHARYNGEAL SWELLING 4 0.0004
327 BLINDNESS TRANSIENT 3 0.0004
328 NASAL POLYPS 2 0.0004
329 LIGAMENT SPRAIN 4 0.0004
330 DIABETIC NEUROPATHY 2 0.0004
331 SINUS DISORDER 8 0.0004
332 ERYSIPELAS 2 0.0004
333 DRUG TOLERANCE 2 0.0004
334 HYPERTHERMIA 3 0.0004
335 ACUTE KIDNEY INJURY 60 0.0004
336 NEUTROPHIL COUNT INCREASED 4 0.0004
337 FEMORAL NECK FRACTURE 2 0.0004
338 ENDOCARDITIS 2 0.0004
339 RIB FRACTURE 8 0.0004
340 FOOD ALLERGY 3 0.0004
341 CEREBRAL ISCHAEMIA 2 0.0004
342 PERIPHERAL VASCULAR DISORDER 2 0.0004
343 TENDONITIS 6 0.0004
344 TRANSFUSION 4 0.0004
345 ANAPHYLACTIC REACTION 21 0.0004
346 ORAL CANDIDIASIS 5 0.0004
347 FULL BLOOD COUNT ABNORMAL 4 0.0004
348 BLOOD PRESSURE FLUCTUATION 9 0.0004
349 FOOD POISONING 2 0.0004
350 PRODUCT DELIVERY MECHANISM ISSUE 2 0.0004
351 BEHAVIOUR DISORDER 2 0.0004
352 HIP SURGERY 2 0.0004
353 ERYTHEMA OF EYELID 2 0.0004
354 POST PROCEDURAL INFECTION 3 0.0004
355 DECUBITUS ULCER 3 0.0004
356 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
357 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
358 HYPERKERATOSIS 2 0.0004
359 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
360 HEMIPLEGIA 3 0.0004
361 EOSINOPHIL COUNT INCREASED 3 0.0004
362 SKIN DISORDER 12 0.0004
363 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
364 NASAL CONGESTION 21 0.0004
365 SKIN INFECTION 4 0.0004
366 SKIN PLAQUE 3 0.0004
367 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
368 URTICARIA 59 0.0004
369 VITAMIN D DECREASED 3 0.0004
370 PRODUCT CONTAINER ISSUE 3 0.0003
371 MUSCULOSKELETAL DISCOMFORT 6 0.0003
372 HYSTERECTOMY 3 0.0003
373 SKIN SWELLING 3 0.0003
374 HYPOTHYROIDISM 11 0.0003
375 METABOLIC DISORDER 2 0.0003
376 RALES 2 0.0003
377 HYPERTRIGLYCERIDAEMIA 2 0.0003
378 COVID-19 PNEUMONIA 4 0.0003
379 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
380 CELLULITIS 17 0.0003
381 CATARACT OPERATION 2 0.0003
382 MACULAR DEGENERATION 4 0.0003
383 STAPHYLOCOCCAL INFECTION 11 0.0003
384 HYPOAESTHESIA ORAL 5 0.0003
385 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
386 LIMB INJURY 9 0.0003
387 INJECTION SITE VESICLES 2 0.0003
388 OSTEOARTHRITIS 14 0.0003
389 FUNGAL INFECTION 11 0.0003
390 BURSITIS 4 0.0003
391 OSTEOPENIA 5 0.0003
392 FOETAL GROWTH RESTRICTION 2 0.0003
393 DERMATITIS ACNEIFORM 2 0.0003
394 PNEUMONIA BACTERIAL 3 0.0003
395 TINNITUS 15 0.0003
396 MENISCUS INJURY 2 0.0003
397 POOR QUALITY SLEEP 7 0.0003
398 DIVERTICULITIS 9 0.0003
399 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
400 PIGMENTATION DISORDER 2 0.0003
401 PRODUCT DISTRIBUTION ISSUE 3 0.0003
402 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
403 EYE SWELLING 12 0.0003
404 HEPATIC ENCEPHALOPATHY 3 0.0003
405 MIDDLE INSOMNIA 6 0.0003
406 APPENDICITIS 3 0.0003
407 NASAL DRYNESS 2 0.0003
408 PRODUCT USE COMPLAINT 5 0.0003
409 RESPIRATORY TRACT CONGESTION 5 0.0003
410 INJECTION SITE IRRITATION 4 0.0003
411 GLAUCOMA 6 0.0003
412 ROTATOR CUFF SYNDROME 4 0.0003
413 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
414 ATELECTASIS 3 0.0003
415 EAR PAIN 6 0.0003
416 AUTOIMMUNE DISORDER 3 0.0003
417 CHOKING 6 0.0003
418 POLYP 2 0.0003
419 EYE DISORDER 10 0.0003
420 MANIA 5 0.0003
421 HOSPICE CARE 3 0.0003
422 SARS-COV-2 TEST POSITIVE 4 0.0003
423 OXYGEN SATURATION DECREASED 17 0.0003
424 CATARACT 18 0.0003
425 BLOOD PRESSURE ABNORMAL 6 0.0003
426 OVARIAN CYST 3 0.0003
427 TOXIC SKIN ERUPTION 3 0.0003
428 POSTOPERATIVE WOUND INFECTION 2 0.0003
429 TASTE DISORDER 6 0.0003
430 PRODUCT LABEL ISSUE 2 0.0003
431 NEUTROPHIL COUNT DECREASED 12 0.0003
432 IMPAIRED GASTRIC EMPTYING 4 0.0003
433 MIGRAINE 28 0.0003
434 AKATHISIA 4 0.0003
435 GINGIVAL BLEEDING 4 0.0003
436 LYMPHOEDEMA 2 0.0003
437 TENDERNESS 3 0.0003
438 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
439 NECK PAIN 16 0.0003
440 FOLLICULITIS 3 0.0003
441 DYSPEPSIA 28 0.0003
442 LYMPHOCYTE COUNT DECREASED 5 0.0003
443 PULMONARY TOXICITY 2 0.0003
444 HEAD DISCOMFORT 5 0.0003
445 HAND FRACTURE 2 0.0003
446 COUGH 79 0.0003
447 INTENTIONAL DOSE OMISSION 8 0.0003
448 RASH 122 0.0003
449 RENAL FAILURE 37 0.0003
450 PRURITUS 107 0.0003
451 FAECES DISCOLOURED 6 0.0003
452 INFECTION 40 0.0003
453 LEUKOCYTOSIS 5 0.0003
454 SKIN LACERATION 3 0.0003
455 URINARY TRACT INFECTION 47 0.0003
456 PULMONARY THROMBOSIS 3 0.0003
457 OESOPHAGITIS 3 0.0003
458 MAJOR DEPRESSION 2 0.0003
459 GASTROINTESTINAL PAIN 3 0.0003
460 RASH ERYTHEMATOUS 13 0.0003
461 HYPOPHOSPHATAEMIA 2 0.0003
462 VIRAL INFECTION 9 0.0003
463 FEELING DRUNK 2 0.0003
464 RESPIRATORY TRACT INFECTION 7 0.0003
465 BACTERIAL INFECTION 5 0.0003
466 RASH PAPULAR 6 0.0003
467 OSTEOPOROSIS 11 0.0003
468 OCULAR DISCOMFORT 3 0.0003
469 FISTULA 3 0.0003
470 GASTRITIS 7 0.0003
471 JOINT SWELLING 32 0.0003
472 MITRAL VALVE INCOMPETENCE 3 0.0003
473 CHEST DISCOMFORT 27 0.0003
474 GASTRIC ULCER 5 0.0003
475 EAR INFECTION 7 0.0003
476 BOWEL MOVEMENT IRREGULARITY 2 0.0003
477 LIPASE INCREASED 2 0.0003
478 NEOPLASM 3 0.0003
479 PROCEDURAL COMPLICATION 2 0.0003
480 MUSCLE TWITCHING 6 0.0003
481 OROPHARYNGEAL PAIN 24 0.0003
482 PRESCRIBED OVERDOSE 5 0.0003
483 APHTHOUS ULCER 2 0.0003
484 LUNG INFECTION 4 0.0003
485 HAEMORRHAGIC STROKE 2 0.0003
486 BONE DENSITY DECREASED 8 0.0003
487 GASTROINTESTINAL INFLAMMATION 2 0.0003
488 DRUG-INDUCED LIVER INJURY 8 0.0003
489 DYSPHAGIA 24 0.0003
490 PROCEDURAL PAIN 7 0.0003
491 NASAL DISCOMFORT 2 0.0003
492 INFLAMMATION 13 0.0003
493 OBESITY 4 0.0003
494 WRIST FRACTURE 3 0.0003
495 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
496 HEPATITIS C 3 0.0002
497 VISION BLURRED 34 0.0002
498 NOCTURIA 3 0.0002
499 FIBROMYALGIA 6 0.0002
500 PRESYNCOPE 6 0.0002
501 SWELLING 23 0.0002
502 SWELLING FACE 16 0.0002
503 THROAT IRRITATION 11 0.0002
504 CYTOPENIA 3 0.0002
505 SMALL INTESTINAL OBSTRUCTION 3 0.0002
506 ERYTHEMA 50 0.0002
507 ILLNESS 25 0.0002
508 ILEUS 3 0.0002
509 APPLICATION SITE IRRITATION 3 0.0002
510 EMBOLISM 2 0.0002
511 PNEUMONIA ASPIRATION 6 0.0002
512 DYSPNOEA 135 0.0002
513 HAEMODIALYSIS 2 0.0002
514 PRODUCT DOSE OMISSION ISSUE 70 0.0002
515 CANDIDA INFECTION 4 0.0002
516 RENAL DISORDER 11 0.0002
517 FACIAL PARALYSIS 2 0.0002
518 ERECTILE DYSFUNCTION 6 0.0002
519 ANAPHYLACTIC SHOCK 6 0.0002
520 PSYCHOLOGICAL TRAUMA 2 0.0002
521 HAEMATOMA 6 0.0002
522 NEUROPATHY PERIPHERAL 22 0.0002
523 MUSCLE STRAIN 2 0.0002
524 THERAPEUTIC RESPONSE DECREASED 14 0.0002
525 PYELONEPHRITIS 2 0.0002
526 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
527 ABDOMINAL DISTENSION 24 0.0002
528 NODULE 3 0.0002
529 PRODUCT DOSE OMISSION 15 0.0002
530 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
531 ARTHRITIS 18 0.0002
532 RASH MACULAR 8 0.0002
533 CONTUSION 22 0.0002
534 TOOTH INFECTION 3 0.0002
535 GRIP STRENGTH DECREASED 2 0.0002
536 PERIPHERAL SWELLING 35 0.0002
537 DRUG INTERACTION 36 0.0002
538 LUNG INFILTRATION 2 0.0002
539 EYE HAEMORRHAGE 3 0.0002
540 FACIAL PAIN 2 0.0002
541 THROMBOSIS 18 0.0002
542 QUALITY OF LIFE DECREASED 3 0.0002
543 MOBILITY DECREASED 16 0.0002
544 PANCREATITIS ACUTE 5 0.0002
545 PSORIASIS 29 0.0002
546 PALPITATIONS 26 0.0002
547 LIP DRY 2 0.0002
548 PELVIC PAIN 4 0.0002
549 PATHOGEN RESISTANCE 2 0.0002
550 EXOSTOSIS 2 0.0002
551 SUICIDAL IDEATION 20 0.0002
552 APPLICATION SITE RASH 3 0.0002
553 NEPHROLITHIASIS 10 0.0002
554 PYREXIA 75 0.0002
555 NERVE COMPRESSION 2 0.0002
556 IRON DEFICIENCY ANAEMIA 2 0.0002
557 BLOOD GLUCOSE ABNORMAL 4 0.0002
558 PERSONALITY CHANGE 2 0.0002
559 HEPATIC FUNCTION ABNORMAL 8 0.0002
560 RENAL IMPAIRMENT 18 0.0002
561 NEPHROPATHY 2 0.0002
562 DIARRHOEA HAEMORRHAGIC 2 0.0002
563 EPISTAXIS 16 0.0002
564 BLISTER 12 0.0002
565 FLANK PAIN 2 0.0002
566 SKIN EXFOLIATION 18 0.0002
567 IMPAIRED HEALING 7 0.0002
568 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
569 SINUS TACHYCARDIA 3 0.0002
570 FEBRILE NEUTROPENIA 14 0.0002
571 BACK PAIN 49 0.0002
572 VISUAL ACUITY REDUCED 7 0.0002
573 BLOOD URINE PRESENT 4 0.0002
574 FALL 70 0.0002
575 VISUAL IMPAIRMENT 26 0.0002
576 DRY SKIN 28 0.0002
577 SUBDURAL HAEMATOMA 3 0.0002
578 AFFECT LABILITY 2 0.0002
579 ANOSMIA 3 0.0002
580 HYPERTHYROIDISM 3 0.0002
581 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
582 HERNIA 4 0.0002
583 SEPTIC SHOCK 9 0.0002
584 FLUSHING 21 0.0002
585 DIZZINESS POSTURAL 2 0.0002
586 INFLUENZA 23 0.0002
587 FLUID OVERLOAD 3 0.0002
588 NEURALGIA 5 0.0002
589 DYSPHONIA 12 0.0002
590 CHEST PAIN 38 0.0002
591 ORAL HERPES 4 0.0002
592 SKIN FISSURES 4 0.0002
593 KNEE OPERATION 2 0.0002
594 URINARY INCONTINENCE 6 0.0002
595 NIGHTMARE 7 0.0002
596 ABDOMINAL PAIN 47 0.0002
597 RENAL INJURY 6 0.0002
598 INABILITY TO AFFORD MEDICATION 2 0.0002
599 HAEMORRHAGE INTRACRANIAL 3 0.0002
600 PRESCRIBED UNDERDOSE 4 0.0002
601 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
602 HYPERKALAEMIA 7 0.0002
603 BLOOD POTASSIUM DECREASED 6 0.0002
604 COVID-19 35 0.0002
605 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
606 ECONOMIC PROBLEM 3 0.0002
607 HEADACHE 124 0.0002
608 HYPOTHERMIA 2 0.0002
609 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
610 PRODUCT COMPLAINT 5 0.0002
611 ARTHRALGIA 82 0.0002
612 CONSTIPATION 43 0.0002
613 EYELID PTOSIS 2 0.0002
614 DRUG LEVEL DECREASED 2 0.0002
615 HIP ARTHROPLASTY 3 0.0002
616 INJECTION SITE SWELLING 15 0.0002
617 EUPHORIC MOOD 2 0.0002
618 HYPOKALAEMIA 9 0.0002
619 DEVICE RELATED INFECTION 3 0.0002
620 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
621 THYROID DISORDER 3 0.0002
622 HELICOBACTER INFECTION 2 0.0002
623 HYPERHIDROSIS 25 0.0002
624 ANKLE FRACTURE 3 0.0002
625 SKIN ULCER 5 0.0002
626 DEPRESSION 44 0.0002
627 POOR VENOUS ACCESS 2 0.0002
628 DIPLOPIA 5 0.0002
629 PANIC ATTACK 7 0.0002
630 RESTLESSNESS 7 0.0002
631 ROAD TRAFFIC ACCIDENT 8 0.0002
632 ABDOMINAL DISCOMFORT 32 0.0002
633 MUSCLE SPASMS 35 0.0002
634 INJECTION SITE DISCOMFORT 2 0.0002
635 EMOTIONAL DISTRESS 23 0.0002
636 INCONTINENCE 2 0.0002
637 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
638 ABSCESS 3 0.0002
639 BODY HEIGHT DECREASED 2 0.0002
640 HYPOGLYCAEMIA 9 0.0002
641 COLITIS 7 0.0002
642 BACK DISORDER 3 0.0002
643 CONDITION AGGRAVATED 56 0.0002
644 BACK INJURY 2 0.0002
645 SOMNOLENCE 37 0.0002
646 MOOD ALTERED 5 0.0002
647 ANXIETY 52 0.0002
648 ASPIRATION 2 0.0002
649 MEMORY IMPAIRMENT 25 0.0002
650 HEART RATE INCREASED 18 0.0002
651 PHOTOSENSITIVITY REACTION 3 0.0002
652 DENTAL CARIES 2 0.0002
653 FOOT DEFORMITY 2 0.0002
654 LIVER DISORDER 8 0.0002
655 HYPOAESTHESIA 27 0.0002
656 COAGULOPATHY 3 0.0002
657 STEVENS-JOHNSON SYNDROME 4 0.0002
658 NERVE INJURY 2 0.0002
659 WOUND 5 0.0002
660 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
661 BLOOD CALCIUM DECREASED 2 0.0002
662 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
663 PAIN IN JAW 5 0.0002
664 PNEUMONIA 57 0.0002
665 MYOCARDIAL ISCHAEMIA 2 0.0002
666 PRODUCT AVAILABILITY ISSUE 4 0.0002
667 DERMATITIS CONTACT 2 0.0002
668 MICTURITION URGENCY 2 0.0002
669 GASTRIC DISORDER 6 0.0002
670 ANGINA PECTORIS 5 0.0002
671 HYPERSOMNIA 5 0.0002
672 SKIN DISCOLOURATION 8 0.0002
673 METASTASES TO LUNG 2 0.0002
674 DYSKINESIA 7 0.0002
675 POST PROCEDURAL HAEMORRHAGE 2 0.0002
676 MUSCULOSKELETAL STIFFNESS 15 0.0002
677 CHILLS 20 0.0002
678 SURGERY 10 0.0002
679 MYALGIA 29 0.0002
680 SEPSIS 19 0.0002
681 COLD SWEAT 3 0.0002
682 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
683 BACTERAEMIA 2 0.0002
684 BLOOD CREATININE INCREASED 11 0.0002
685 PRODUCT ADHESION ISSUE 6 0.0002
686 POLLAKIURIA 7 0.0002
687 HYPERLIPIDAEMIA 2 0.0002
688 MUSCULAR WEAKNESS 19 0.0002
689 POLYNEUROPATHY 2 0.0002
690 DIZZINESS 83 0.0002
691 RASH PRURITIC 9 0.0002
692 TOOTHACHE 3 0.0002
693 BLOOD PRESSURE DECREASED 11 0.0002
694 PRODUCT USE IN UNAPPROVED INDICATION 41 0.0002
695 LOCALISED INFECTION 4 0.0002
696 ABDOMINAL PAIN UPPER 34 0.0002
697 MENTAL IMPAIRMENT 4 0.0002
698 C-REACTIVE PROTEIN INCREASED 6 0.0002
699 CEREBRAL INFARCTION 4 0.0002
700 DECREASED APPETITE 38 0.0002
701 AGITATION 12 0.0002
702 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
703 HYPOACUSIS 7 0.0002
704 DRUG INEFFECTIVE 214 0.0002
705 INJECTION SITE EXTRAVASATION 2 0.0002
706 DYSGEUSIA 12 0.0002
707 AGRANULOCYTOSIS 3 0.0002
708 MENTAL DISORDER 7 0.0002
709 WEIGHT INCREASED 36 0.0002
710 HAIR COLOUR CHANGES 2 0.0002
711 INJECTION SITE DISCOLOURATION 2 0.0002
712 PARAESTHESIA 25 0.0002
713 FLATULENCE 9 0.0002
714 FRACTURE 3 0.0002
715 MUSCLE ATROPHY 2 0.0002
716 HAEMATEMESIS 4 0.0002
717 TACHYCARDIA 14 0.0002
718 DEHYDRATION 21 0.0002
719 NASOPHARYNGITIS 29 0.0002
720 FATIGUE 122 0.0002
721 GASTROINTESTINAL DISORDER 14 0.0002
722 ACUTE RESPIRATORY FAILURE 3 0.0002
723 THERAPY NON-RESPONDER 7 0.0002
724 GENITAL HAEMORRHAGE 2 0.0002
725 NIGHT SWEATS 5 0.0002
726 DYSTONIA 3 0.0002
727 PAIN 95 0.0002
728 HYPOTENSION 31 0.0002
729 INJECTION SITE INDURATION 2 0.0002
730 AMNESIA 10 0.0002
731 DEAFNESS 4 0.0002
732 CHOLELITHIASIS 5 0.0002
733 DEPRESSED MOOD 8 0.0002
734 UPPER LIMB FRACTURE 3 0.0002
735 EXPIRED PRODUCT ADMINISTERED 5 0.0002
736 BALANCE DISORDER 13 0.0002
737 URINARY RETENTION 5 0.0001
738 PAIN IN EXTREMITY 44 0.0001
739 JOINT RANGE OF MOTION DECREASED 2 0.0001
740 DISTURBANCE IN ATTENTION 8 0.0001
741 BLOOD BILIRUBIN INCREASED 4 0.0001
742 ANGER 5 0.0001
743 DIARRHOEA 95 0.0001
744 FEELING HOT 9 0.0001
745 HYPERTENSION 31 0.0001
746 UNEVALUABLE EVENT 11 0.0001
747 NAUSEA 114 0.0001
748 FEELING COLD 4 0.0001
749 HYPOMAGNESAEMIA 2 0.0001
750 MASS 2 0.0001
751 CARPAL TUNNEL SYNDROME 2 0.0001
752 HALLUCINATION, VISUAL 3 0.0001
753 HYPOXIA 5 0.0001
754 LYMPHADENOPATHY 5 0.0001
755 JOINT INJURY 3 0.0001
756 THERAPY INTERRUPTED 10 0.0001
757 OEDEMA PERIPHERAL 17 0.0001
758 PARAESTHESIA ORAL 2 0.0001
759 PRODUCT USE ISSUE 26 0.0001
760 PRODUCT PRESCRIBING ISSUE 3 0.0001
761 FLUID RETENTION 7 0.0001
762 LIVER FUNCTION TEST ABNORMAL 4 0.0001
763 ALOPECIA 27 0.0001
764 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
765 GASTROENTERITIS 2 0.0001
766 DYSSTASIA 4 0.0001
767 THERAPY CESSATION 7 0.0001
768 DYSURIA 5 0.0001
769 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
770 TOOTH DISORDER 3 0.0001
771 COLON CANCER 2 0.0001
772 INFLUENZA LIKE ILLNESS 11 0.0001
773 ADVERSE DRUG REACTION 12 0.0001
774 SPEECH DISORDER 7 0.0001
775 HEART RATE IRREGULAR 3 0.0001
776 LOSS OF CONSCIOUSNESS 17 0.0001
777 WEIGHT DECREASED 37 0.0001
778 APPLICATION SITE PRURITUS 3 0.0001
779 RHEUMATOID ARTHRITIS 15 0.0001
780 DEVICE FAILURE 2 0.0001
781 ADVERSE EVENT 12 0.0001
782 MUSCULOSKELETAL CHEST PAIN 2 0.0001
783 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
784 BLOOD CHOLESTEROL INCREASED 6 0.0001
785 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
786 OFF LABEL USE 111 0.0001
787 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
788 PRODUCT PRESCRIBING ERROR 3 0.0001
789 CYSTITIS 4 0.0001
790 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
791 MOVEMENT DISORDER 4 0.0001
792 HYPONATRAEMIA 7 0.0001
793 CONFUSIONAL STATE 20 0.0001
794 BLOOD POTASSIUM INCREASED 2 0.0001
795 INJECTION SITE URTICARIA 3 0.0001
796 ENCEPHALOPATHY 3 0.0001
797 PLATELET COUNT DECREASED 13 0.0001
798 MULTIPLE FRACTURES 2 0.0001
799 PRODUCT SUBSTITUTION ISSUE 7 0.0001
800 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
801 INFUSION RELATED REACTION 8 0.0001
802 GAIT DISTURBANCE 23 0.0001
803 GAIT INABILITY 4 0.0001
804 ASTHENIA 45 0.0001
805 BONE PAIN 7 0.0001
806 PERICARDITIS 2 0.0001
807 ABDOMINAL PAIN LOWER 3 0.0001
808 FACE OEDEMA 2 0.0001
809 HYPOPHAGIA 3 0.0001
810 HOSPITALISATION 18 0.0001
811 VOMITING 55 0.0001
812 HAEMATURIA 4 0.0001
813 PARANOIA 2 0.0001
814 EXPOSURE VIA SKIN CONTACT 3 0.0001
815 PLEURAL EFFUSION 7 0.0001
816 MUCOSAL INFLAMMATION 3 0.0001
817 MUSCULOSKELETAL PAIN 6 0.0001
818 DEVICE USE ISSUE 2 0.0001
819 EOSINOPHILIA 2 0.0001
820 BURNING SENSATION 8 0.0001
821 METASTASES TO LIVER 2 0.0001
822 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
823 BRADYCARDIA 6 0.0001
824 FEELING ABNORMAL 27 0.0001
825 SEIZURE 13 0.0001
826 ISCHAEMIC STROKE 2 0.0001
827 COLITIS ULCERATIVE 5 0.0001
828 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
829 PALLOR 3 0.0001
830 DRUG EFFECT INCOMPLETE 4 0.0001
831 SYNCOPE 11 0.0001
832 MALAISE 48 0.0001
833 SKIN IRRITATION 5 0.0001
834 HAEMATOCHEZIA 6 0.0001
835 RESPIRATORY DISTRESS 3 0.0001
836 ABNORMAL DREAMS 3 0.0001
837 TREMOR 18 0.0001
838 INJECTION SITE MASS 4 0.0001
839 ARTHROPATHY 6 0.0001
840 HEPATIC STEATOSIS 2 0.0001
841 PANCYTOPENIA 6 0.0001
842 HEPATIC CIRRHOSIS 2 0.0001
843 CEREBROVASCULAR ACCIDENT 18 0.0001
844 BLOOD SODIUM DECREASED 2 0.0001
845 PROTEINURIA 2 0.0001
846 DISEASE RECURRENCE 5 0.0001
847 MUSCULOSKELETAL DISORDER 2 0.0001
848 DIABETES MELLITUS 8 0.0001
849 RED BLOOD CELL COUNT DECREASED 3 0.0001
850 ANAEMIA 20 0.0001
851 INJECTION SITE ERYTHEMA 13 0.0001
852 INCREASED APPETITE 2 0.0001
853 BLOOD PRESSURE INCREASED 16 0.0001
854 MULTIPLE SCLEROSIS 5 0.0001
855 INJECTION SITE PRURITUS 7 0.0001
856 LOWER LIMB FRACTURE 2 0.0001
857 ERUCTATION 2 0.0001
858 INTERSTITIAL LUNG DISEASE 5 0.0001
859 NEEDLE ISSUE 3 0.0001
860 KIDNEY INFECTION 2 0.0001
861 PSYCHOTIC DISORDER 3 0.0001
862 INJECTION SITE PAIN 31 0.0001
863 ABNORMAL BEHAVIOUR 4 0.0001
864 HAEMATOCRIT DECREASED 2 0.0001
865 NO ADVERSE EVENT 18 0.0001
866 FULL BLOOD COUNT DECREASED 2 0.0001
867 PRODUCT PHYSICAL ISSUE 2 0.0001
868 DRY MOUTH 8 0.0001
869 BLINDNESS 4 0.0001
870 EPILEPSY 3 0.0001
871 BODY TEMPERATURE INCREASED 2 0.0001
872 INJECTION SITE RASH 3 0.0001
873 HAEMOGLOBIN DECREASED 10 0.0001
874 PRODUCT PREPARATION ERROR 2 0.0001
875 EMOTIONAL DISORDER 3 0.0001
876 INJECTION SITE WARMTH 2 0.0001
877 NERVOUS SYSTEM DISORDER 3 0.0001
878 PULMONARY HYPERTENSION 2 0.0001
879 KNEE ARTHROPLASTY 2 0.0001
880 MOOD SWINGS 3 0.0001
881 IRRITABLE BOWEL SYNDROME 2 0.0001
882 DRUG INTOLERANCE 9 0.0001
883 LIVER FUNCTION TEST INCREASED 2 0.0001
884 HALLUCINATION 7 0.0001
885 HOT FLUSH 7 0.0001
886 PRURITUS GENERALISED 2 0.0001
887 DEEP VEIN THROMBOSIS 6 0.0001
888 DEVICE LEAKAGE 4 0.0001
889 OSTEONECROSIS 3 0.0001
890 MELAENA 2 0.0001
891 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
892 INSOMNIA 24 0.0001
893 MEDICATION ERROR 5 0.0001
894 ORAL PAIN 2 0.0001
895 TYPE 2 DIABETES MELLITUS 3 0.0001
896 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
897 HEPATIC ENZYME INCREASED 6 0.0001
898 INJECTION SITE BRUISING 7 0.0001
899 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
900 HERPES ZOSTER 5 0.0001
901 INJURY 6 0.0001
902 DRUG DOSE OMISSION 14 0.0001
903 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
904 SKIN BURNING SENSATION 6 0.0001
905 STOMATITIS 5 0.0001
906 RESPIRATORY FAILURE 6 0.0001
907 LUNG DISORDER 4 0.0001
908 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
909 INTENTIONAL PRODUCT MISUSE 7 0.0001
910 DYSARTHRIA 3 0.0001
911 INTESTINAL OBSTRUCTION 3 0.0001
912 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
913 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
914 DEVICE ISSUE 7 0.0001
915 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
916 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
917 RASH GENERALISED 2 0.0001
918 DEVICE EXPULSION 5 0.0001
919 PLASMA CELL MYELOMA 3 0.0001
920 NERVOUSNESS 4 0.0001
921 APPLICATION SITE ERYTHEMA 2 0.0001
922 DISEASE PROGRESSION 9 0.0001
923 DISORIENTATION 3 0.0001
924 PANCREATITIS 4 0.0001
925 INJECTION SITE HAEMORRHAGE 6 0.0001
926 MENSTRUATION IRREGULAR 2 0.0001
927 INCORRECT DOSE ADMINISTERED 17 0.0001
928 JAUNDICE 2 0.0001
929 EXTRA DOSE ADMINISTERED 3 0.0001
930 FREQUENT BOWEL MOVEMENTS 2 0.0001
931 PULMONARY EMBOLISM 7 0.0001
932 PRODUCT QUALITY ISSUE 10 0.0001
933 NEUTROPENIA 10 0.0001
934 PNEUMONITIS 2 0.0001
935 INJECTION SITE REACTION 5 0.0001
936 DEMENTIA 2 0.0001
937 WITHDRAWAL SYNDROME 3 0.0001
938 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
939 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
940 RECTAL HAEMORRHAGE 3 0.0001
941 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
943 ACUTE MYOCARDIAL INFARCTION 2 0.0001
944 LABORATORY TEST ABNORMAL 2 0.0001
945 ACNE 5 0.0001
946 ILL-DEFINED DISORDER 4 0.0001
947 COGNITIVE DISORDER 3 0.0001
948 HEAD INJURY 2 0.0001
949 THROMBOCYTOPENIA 7 0.0001
950 BLOOD GLUCOSE DECREASED 3 0.0001
951 HIP FRACTURE 2 0.0001
952 ATRIAL FIBRILLATION 6 0.0001
953 AGGRESSION 3 0.0001
954 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
955 NEOPLASM PROGRESSION 2 0.0001
956 HEART RATE DECREASED 2 0.0001
957 CEREBRAL HAEMORRHAGE 2 0.0001
958 OEDEMA 3 0.0001
959 HYPERGLYCAEMIA 2 0.0001
960 LETHARGY 3 0.0001
961 ABORTION SPONTANEOUS 2 0.0000
962 CARDIAC FAILURE CONGESTIVE 4 0.0000
963 DEVICE BREAKAGE 2 0.0000
964 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
965 HAEMORRHAGE 5 0.0000
966 PRODUCT STORAGE ERROR 4 0.0000
967 DEVICE DIFFICULT TO USE 3 0.0000
968 PULMONARY OEDEMA 2 0.0000
969 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
970 DEVICE MALFUNCTION 3 0.0000
971 BLOOD GLUCOSE INCREASED 8 0.0000
972 ARRHYTHMIA 2 0.0000
973 COMA 2 0.0000
974 UNDERDOSE 3 0.0000
975 LEUKOPENIA 2 0.0000
976 CARDIAC FAILURE 3 0.0000
977 OVERDOSE 8 0.0000
978 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
979 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
980 DEATH 29 0.0000
981 IRRITABILITY 2 0.0000
982 TOXICITY TO VARIOUS AGENTS 5 0.0000
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
984 PROSTATE CANCER 2 0.0000
985 DRUG ABUSE 2 0.0000
986 MYOCARDIAL INFARCTION 4 0.0000
987 BREAST CANCER 2 0.0000
988 DRUG DEPENDENCE 3 0.0000